191 related articles for article (PubMed ID: 33207358)
21. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
[TBL] [Abstract][Full Text] [Related]
22. Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases: Erratum.
Nucl Med Commun; 2024 Apr; 45(4):353. PubMed ID: 38446124
[No Abstract] [Full Text] [Related]
23. Liver transplantation for advanced-stage primary hepatic yolk sac tumor: A case report and literature review.
Liu GH; Qiu MK; Wang Y; Zhang TT; Wang LJ; Guan WB; Ou JM; Chen LT
Medicine (Baltimore); 2023 Dec; 102(50):e35821. PubMed ID: 38115376
[TBL] [Abstract][Full Text] [Related]
24. PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma.
Lee Z; Lu ZR; Sexton S; Xin W
Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3190-3191. PubMed ID: 37405467
[No Abstract] [Full Text] [Related]
25. Progression of Myocardial 18F-FDG Uptake in a Patient with Cardiotoxicity.
Berenguer DRF; de Moraes Chaves Becker M; de Oliveira Buril R; Bertão PA; Markman Filho B; Brandão SCS
Arq Bras Cardiol; 2024; 121(2):e20230276. PubMed ID: 38422307
[TBL] [Abstract][Full Text] [Related]
26. Assessment of perineural spread in advanced cutaneous squamous cell carcinomas treated with immunotherapy.
Cavanagh K; McLean LS; Lim AM; Cardin A; Levy SM; Rischin D
Cancer Imaging; 2024 Mar; 24(1):37. PubMed ID: 38500235
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of pre-treatment 18F-FDG PET/CT parameters in endometrial cancer.
Pacella S; Grappeja L
Ann Nucl Med; 2024 Jan; 38(1):85. PubMed ID: 38012336
[No Abstract] [Full Text] [Related]
28. Impact of radiological response and pattern of progression in patients with HCC treated by atezolizumab-bevacizumab.
Campani C; Vallot A; Ghannouchi H; Allaire M; Evain M; Sultanik P; Sidali S; Blaise L; Thabut D; Nahon P; Seror O; Ganne-Carrié N; Nault JC; Wagner M; Sutter O
Hepatology; 2024 Jan; 79(1):49-60. PubMed ID: 37870270
[TBL] [Abstract][Full Text] [Related]
29. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities.
Shimizu R; Ida Y; Kitano M
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835800
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review.
Dondi F; Albano D; Giubbini R; Bertagna F
Nucl Med Commun; 2021 Dec; 42(12):1293-1300. PubMed ID: 34456317
[TBL] [Abstract][Full Text] [Related]
31. Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography-Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer.
Anılır E; Oral A; Turker F; Şahin T; Topçu FS; Yuzer Y; Tokat Y
Transplant Proc; 2024; 56(1):111-115. PubMed ID: 38212168
[TBL] [Abstract][Full Text] [Related]
32. Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy.
Li ZC; Wang J; Liu HB; Zheng YM; Huang JH; Cai JB; Zhang L; Liu X; Du L; Yang XT; Chai XQ; Jiang YH; Ren ZG; Zhou J; Fan J; Yu DC; Sun HC; Huang C; Liu F
Cell Rep; 2024 Mar; 43(3):113877. PubMed ID: 38421869
[TBL] [Abstract][Full Text] [Related]
33. A case of hepatocellular carcinoma with pseudoaneurysm formation upon lenvatinib administration.
Yano R; Hirooka M; Nakamura Y; Imai Y; Koizumi Y; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
Clin J Gastroenterol; 2024 Apr; 17(2):319-326. PubMed ID: 38281290
[TBL] [Abstract][Full Text] [Related]
34. Ectopic, CRH-responsive Cushing syndrome with negative 68Ga-DOTATATE and 18F-FDG PET/CT imaging findings and pituitary microadenoma: a challenging case with a successful outcome.
Gilis-Januszewska A; Gamrat A; Minasyan M; Bogusławska A; Rzepka E; Hubalewska-Dydejczyk A
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 37622169
[No Abstract] [Full Text] [Related]
35. Innovations in Positron Emission Tomography and State of the Art in the Evaluation of Breast Cancer Treatment Response.
Castorina L; Comis AD; Prestifilippo A; Quartuccio N; Panareo S; Filippi L; Castorina S; Giuffrida D
J Clin Med; 2023 Dec; 13(1):. PubMed ID: 38202160
[TBL] [Abstract][Full Text] [Related]
36. Why Uptake Matters? - A Case of the Second Primary in a Benign-Looking Renal Cyst of a Patient Undergoing 18f-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Treated Head-And-Neck Cancer.
Sharma A; Dwivedi A; Sawhney S; Sancheti S
Indian J Nucl Med; 2022; 37(4):398-399. PubMed ID: 36817199
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG-PET/CT imaging of aseptic abscess syndrome mimicking metastatic disease or granulomatosis.
Masse M; Razzouk-Cadet M
Pol Arch Intern Med; 2023 Oct; 133(10):. PubMed ID: 37732888
[No Abstract] [Full Text] [Related]
38. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Rare Case of Epithelioid Hemangioendothelioma - A Diagnostic Challenge.
Nisamudeen F; Prabhu M; Bihari C; Sarangi J; Yadav HP
Indian J Nucl Med; 2023; 38(3):282-285. PubMed ID: 38046956
[TBL] [Abstract][Full Text] [Related]
39. Microscopic Residual Disease After Nasal Squamous Cell Carcinoma Not Visualized on FDG PET-CT: A Case Report.
Tsuda T; Fukusumi T; Saito M; Kuki A; Inohara H
Cureus; 2023 Oct; 15(10):e47451. PubMed ID: 38022262
[TBL] [Abstract][Full Text] [Related]
40. Clinical usefulness of post-operative 18F-fluorodeoxyglucose positron emission tomography-computed tomography in canine hemangiosarcoma.
Lee G; Kwon SY; Son K; Park S; Lee JH; Cho KO; Min JJ; Choi J
J Vet Sci; 2016 Jun; 17(2):257-260. PubMed ID: 26645332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
